BR112022021479A2 - Variantes, formulações e métodos adeno-associados para entrega pulmonar - Google Patents
Variantes, formulações e métodos adeno-associados para entrega pulmonarInfo
- Publication number
- BR112022021479A2 BR112022021479A2 BR112022021479A BR112022021479A BR112022021479A2 BR 112022021479 A2 BR112022021479 A2 BR 112022021479A2 BR 112022021479 A BR112022021479 A BR 112022021479A BR 112022021479 A BR112022021479 A BR 112022021479A BR 112022021479 A2 BR112022021479 A2 BR 112022021479A2
- Authority
- BR
- Brazil
- Prior art keywords
- adeno
- variants
- formulations
- pulmonary delivery
- associated methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4712—Cystic fibrosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14142—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
VARIANTES, FORMULAÇÕES E MÉTODOS ADENO-ASSOCIADOS PARA ENTREGA PULMONAR. A presente revelação fornece uma proteína do capsídeo de AAV variante que confere tropismo às células pulmonares e vírus adeno-associados recombinantes que compreendem a variante AAV e composições farmacêuticas que compreendem as mesmas e seu uso na entrega de ácidos nucleicos heterólogos às células para o tratamento de doenças pulmonares.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063016246P | 2020-04-27 | 2020-04-27 | |
US202063088432P | 2020-10-06 | 2020-10-06 | |
PCT/US2021/029253 WO2021222148A2 (en) | 2020-04-27 | 2021-04-26 | Adeno-associated variants, formulations and methods for pulmonary delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022021479A2 true BR112022021479A2 (pt) | 2022-12-13 |
Family
ID=78332150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022021479A BR112022021479A2 (pt) | 2020-04-27 | 2021-04-26 | Variantes, formulações e métodos adeno-associados para entrega pulmonar |
Country Status (12)
Country | Link |
---|---|
US (3) | US11499166B2 (pt) |
EP (1) | EP4100539A4 (pt) |
JP (2) | JP7393565B2 (pt) |
KR (1) | KR20230026985A (pt) |
CN (1) | CN115552021A (pt) |
AU (2) | AU2021265768B2 (pt) |
BR (1) | BR112022021479A2 (pt) |
CA (1) | CA3172260A1 (pt) |
IL (1) | IL296445A (pt) |
MX (1) | MX2022013462A (pt) |
WO (1) | WO2021222148A2 (pt) |
ZA (1) | ZA202210026B (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7393565B2 (ja) * | 2020-04-27 | 2023-12-06 | 4ディー モレキュラー セラピューティクス インコーポレイテッド | 肺送達のためのアデノ随伴バリアント、製剤および方法 |
WO2023172873A2 (en) * | 2022-03-07 | 2023-09-14 | 4D Molecular Therapeutics Inc. | Adeno-associated virus variant capsids with improved lung tropism and uses thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005056762A2 (en) | 2003-12-05 | 2005-06-23 | University Of Iowa Research Foundation | Truncated cmv promoters and vectors containing same |
WO2006036465A2 (en) | 2004-09-03 | 2006-04-06 | University Of Florida | Compositions and methods for treating cystic fibrosis |
CA2907799A1 (en) | 2013-05-31 | 2014-12-04 | The Regents Of The University Of California | Adeno-associated virus variants and methods of use thereof |
WO2017201121A1 (en) * | 2016-05-17 | 2017-11-23 | University Of Florida Research Foundation, Inc. | Recombinant aav for gene therapy in lungs |
MA47603A (fr) | 2017-02-27 | 2020-01-01 | Translate Bio Inc | Nouvel arnm cftr à codons optimisés |
WO2018213476A1 (en) | 2017-05-16 | 2018-11-22 | Translate Bio, Inc. | Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr |
WO2020014479A1 (en) | 2018-07-11 | 2020-01-16 | Baxalta Incorporated | Aav compositions |
MX2021006646A (es) * | 2018-12-05 | 2021-12-10 | Abeona Therapeutics Inc | Vector viral adenoasociado recombinante para el suministro de genes. |
JP2022529002A (ja) * | 2019-04-19 | 2022-06-16 | レジェンクスバイオ インコーポレーテッド | アデノ随伴ウイルスベクター製剤及び方法 |
JP7393565B2 (ja) * | 2020-04-27 | 2023-12-06 | 4ディー モレキュラー セラピューティクス インコーポレイテッド | 肺送達のためのアデノ随伴バリアント、製剤および方法 |
-
2021
- 2021-04-26 JP JP2022564245A patent/JP7393565B2/ja active Active
- 2021-04-26 EP EP21796101.0A patent/EP4100539A4/en active Pending
- 2021-04-26 MX MX2022013462A patent/MX2022013462A/es unknown
- 2021-04-26 BR BR112022021479A patent/BR112022021479A2/pt unknown
- 2021-04-26 AU AU2021265768A patent/AU2021265768B2/en active Active
- 2021-04-26 IL IL296445A patent/IL296445A/en unknown
- 2021-04-26 US US17/241,032 patent/US11499166B2/en active Active
- 2021-04-26 CA CA3172260A patent/CA3172260A1/en active Pending
- 2021-04-26 KR KR1020227036954A patent/KR20230026985A/ko active Search and Examination
- 2021-04-26 CN CN202180031111.7A patent/CN115552021A/zh active Pending
- 2021-04-26 WO PCT/US2021/029253 patent/WO2021222148A2/en unknown
-
2022
- 2022-09-08 ZA ZA2022/10026A patent/ZA202210026B/en unknown
- 2022-10-06 US US17/938,641 patent/US11807868B2/en active Active
-
2023
- 2023-04-13 AU AU2023202289A patent/AU2023202289A1/en active Pending
- 2023-06-23 JP JP2023103309A patent/JP2023123668A/ja active Pending
- 2023-09-15 US US18/468,142 patent/US20240067987A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2023202289A1 (en) | 2023-05-11 |
US11807868B2 (en) | 2023-11-07 |
MX2022013462A (es) | 2022-11-16 |
US20210395772A1 (en) | 2021-12-23 |
EP4100539A2 (en) | 2022-12-14 |
JP2023123668A (ja) | 2023-09-05 |
AU2021265768A1 (en) | 2022-11-03 |
AU2021265768B2 (en) | 2023-03-30 |
US11499166B2 (en) | 2022-11-15 |
EP4100539A4 (en) | 2023-11-22 |
CN115552021A (zh) | 2022-12-30 |
WO2021222148A2 (en) | 2021-11-04 |
CA3172260A1 (en) | 2021-11-04 |
ZA202210026B (en) | 2024-01-31 |
WO2021222148A3 (en) | 2021-12-02 |
US20230257772A1 (en) | 2023-08-17 |
JP7393565B2 (ja) | 2023-12-06 |
US20240067987A1 (en) | 2024-02-29 |
KR20230026985A (ko) | 2023-02-27 |
IL296445A (en) | 2022-11-01 |
JP2023516223A (ja) | 2023-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112022021479A2 (pt) | Variantes, formulações e métodos adeno-associados para entrega pulmonar | |
Chavda et al. | Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management | |
BR112022023106A2 (pt) | Redirecionamento de tropismo de capsídeos de aav | |
BR112018003665A2 (pt) | métodos e composições para vetores virais de evasão de anticorpo | |
ES2752191T3 (es) | Composiciones y métodos con vectores de AAV para la transferencia de genes a células, órganos y tejidos | |
CO2020004738A2 (es) | Variantes de cápsides de virus adenoasociados y métodos de uso de estas | |
BR112018072849A2 (pt) | capsídeos variantes de vírus adeno associado e métodos de uso | |
AU2017207917B2 (en) | Recombinant AAV vectors expressing osteoprotective genes, including HAS2 and lubricin, useful in the treatment of osteoarthritis and related joint conditions in mammals | |
BR112014025985A2 (pt) | composição e métodos para transferência de gene altamente eficaz com o uso de variantes de capsídeo de aav | |
CN104144941B (zh) | 以计算方式优化的人和禽h5n1流感的广泛反应性抗原 | |
BR112014009022A2 (pt) | formulações de etanercepte estabilizadas com combinações de açúcares e polióis | |
PE20231949A1 (es) | VARIANTES DEL FACTOR VIII REDUCIDO CON CpG, COMPOSICIONES Y METODOS Y USOS PARA EL TRATAMIENTO DE TRASTORNOS DE LA HEMOSTASIA | |
BR112019002904A2 (pt) | métodos e composições para transferência gênica direcionada | |
KR20160033217A (ko) | 변종 aav 및 조성물, 세포, 기관 및 조직으로의 유전자 전이를 위한 방법 및 용도 | |
BR112012023517A2 (pt) | Preparação de enzima pancreática (pep) tendo infectividade viral reduzida, composição farmacêutica tendo infectividade viral reduzida, forma de dosagem oral sólida, método para tratar insuficiência pancreática em um paciente que necessita disso e método para preparar um apreparação de enzima pancreática (pep) | |
BR112021023692A2 (pt) | Partícula viral de vírus adeno-associado recombinante, proteína de capsídeo de vírus adeno-associado, molécula de ácido nucleico, célula empacotadora, métodos de produção de uma partícula viral e de distribuição de um nucleotídeo, e, composição farmacêutica | |
EA021009B1 (ru) | ОБРАТНАЯ ГЕНЕТИКА С ИСПОЛЬЗОВАНИЕМ НЕЭНДОГЕННЫХ ПРОМОТОРОВ pol I | |
CO2022010227A2 (es) | Proteínas de la cápside de virus adeno-asociados modificadas para la terapia génica ocular y métodos de uso de las mismas | |
CO2022015313A2 (es) | Variantes de cápsides de aav y usos de los mismos | |
McClain et al. | Vector serotype screening for use in ovine perinatal lung gene therapy | |
ES2403098T3 (es) | Suplemento de medios para la producción de virus | |
BR112017024283A2 (pt) | vacinas contra a dengue | |
JP2017528511A (ja) | 免疫低下された被験体のワクチン接種 | |
US20230116082A1 (en) | Methods and compositions for treating tissue damage resulting from viral infections | |
WO2023172873A3 (en) | Adeno-associated virus variant capsids with improved lung tropism and uses thereof |